IntelGenx Technologies Corp.

Common Stock SEC Reporting - Current
OTCQX U.S. OTCQX Advisor: Dorsey & Whitney LLP
Verified Company Profile 6/14/2016
Contact Info
  • 6420 Abrams
  • St. Laurent, QC H4S 1Y2
  • Canada

Business Description

Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Sep 30, 2016 10-Q
CIK 0001098880
Fiscal Year End 12/31
OTC Marketplace OTCQX U.S.
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: DE, USA
Year of Inc. 2003
Employees 20 a/o Mar 01, 2016
Company Officers/Contacts
Horst G. Zerbe, Ph.D CEO, President
Ingrid Zerbe Corporate Secretary
Karen Kalajajian Controller
Edward Miller IR
Company Directors
Horst G. Zerbe, Ph.D Chairman
J. Bernard Boudreau
Service Providers
OTCQX Advisor
Dorsey & Whitney LLP
1400 Wewatta Street
Suite 400
Denver, CO, 80202

Accounting/Auditing Firm
Richter LLC.
1981 McGill College
Montreal, QC, H3A 0G6

Legal Counsel
Dorsey & Whitney LLP
TD Canada Trust Tower Brookfield Place
161 Bay Street
Suite 4310
Toronto, ONT, M5J 2S1

Investor Relations Firm
Not Available
IGXT Security Details
Share Structure
Market Value1 $51,731,150 a/o Dec 02, 2016
Authorized Shares 100,000,000 a/o Jun 09, 2015
Outstanding Shares 64,672,021 a/o Nov 09, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 52,261,557 a/o Jun 09, 2015
Par Value 0.00001
Shareholders of Record 46 a/o Mar 30, 2016
Short Selling Data
Short Interest 3,805 (-46.92%)
Nov 15, 2016
Significant Failures to Deliver No

1Market Value calculated only for respective security